| |
|
浅香正博 |
北海道医療大学 学長 |
| 消化器病学、がん予防学 |
| Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan. Tsuda M, Asaka M, Kato M, Matsushima R,. Fujimori K, Akino K, Kikuchi S, Lin Y, Sakamoto N. Helicobacter 2017 22: e12415
|
| Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Gut. 65:1439-1446,2016
|
| Increased ghrelin signaling prolongs survival in mouse models of human aging through activation of sirtuin1. Fujitsuka N, Asakawa A, Morinaga A, Amitani MS, Amitani H, Katsuura G, Sawada Y, Sudo Y, Uezono Y, Mochiki E, Sakata I, Sakai T, Hanazaki K, Yada T, Yakabi K, Sakuma E, Ueki T, Niijima A, Nakagawa K, Okubo N, Takeda H, Asaka M, Inui A Mol Psychiatry. 2016 21:1613-1623.
|
|
| ○ |
|
五十嵐 隆 |
国立成育医療研究センター理事長 |
| 小児科学 |
|
Igarashi T, Gu:nter W, Sekine T, Inatomi J, Shiraga H, Takahashi S, Suzuki J, Tsuru N, Yanagihara T, Shimazu M, Jentsch TJ, Thakker RV: Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent’s Japan disease. Kidney Int 54: 1850-1856, 1998
|
|
Igarashi T, Inatomi J, Sekine T, Cha SH, Kanai Y, Kunimi M, Tsukamoto K, Satoh H, Shimadzu M, Tozawa F, Mori T, Shiobara M, Seki G, Endou H: Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nature Genet 23:264-266, 1999
|
|
Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H: Molecular identification of a renal/urate/anion exchanger that regulates blood urate levels. Nature 417: 447-452, 2002
|
|
| |
|
石橋 達朗 |
九州大学 理事・副学長 |
| 眼科 |
Ishikawa K, Yoshida S, Nakao S, Nakama T, Kita T, Asato R, Sassa Y, Arita R, Miyazaki M, Enaida H, Oshima Y, Murakami N, Niiro H, Ono J, Matsuda A, Goto Y, Akashi K, Izuhara K, Kudo A,Kono T, Hafezi-Moghadam A, Ishibashi T:
Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J 28(1):131-142, 2014
|
Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M, Ishibashi T:
Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
Gene Ther 22(2):127-137, 2015
|
Ishibashi T, Li X, Koh A, Lai, Lee F-L, Lee W-K, Ma Z, Ohji M,Tan N,
Cha S B, Shamsazar J, Yau C L, on behalf of the REVEAL Study
Group:The REVEAL Study : Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.
Ophthalmology 122(7):1402-1415, 2015
|
|
| |
|
長村義之 |
日本鋼管病院 部長、慶應義塾大学 客員教授 |
| 病理学 ゲノム病理学 |
| WHO Classification of Tumours of Endocrine Organs, WHO/IARC Classification of Tumours, 4th Edition, Volume 10, 2017, Edited by Lloyd RV, Osamura RY, Klo:ppel G, Rosai J,
|
| Histopathology and Cytopathology of Neuroendocrine Tumors and Carcinomas of the Breast: A Review. Osamura RY, Matsui N, Okubo M, et al. Acta Cytol 2019;63:340-346. |
| The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology. Field AS, Raymond WA, Rickard M, Arnold L, Brachtel EF, Chaiwun B, Chen L, Di Bonito L, Kurtycz DFI, Lee AHS, Lim E, Ljung BM, Michelow P, Osamura RY, et al. Acta Cytol 2019;63:257-273. |
|
| |
|
片山一朗 |
大阪市立大学大学院医学研究科 特任教授 |
| 皮膚科学 |
| Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment. Ono E, Murota H, Mori Y, Yoshioka Y, Nomura Y, Munetsugu T, Yokozeki H, Katayama I. PLoS One. 2018 Apr 20;13(4):e0195960. d56
|
| Local Glucocorticoid Activation by 11β-Hydroxysteroid Dehydrogenase 1 in Keratinocytes: The Role in Hapten-Induced Dermatitis. Terao M, Itoi S, Matsumura S, Yang L, Murota H, Katayama I Am J Pathol. 2016;186(6):1499-510.
|
| Dose-dependent role of claudin-1 in vivo in orchestrating features of atopic dermatitis. )Tokumasu R, Yamaga K, Yamazaki Y, Murota H, Suzuki K, Tamura A, Bando K, Furuta Y, Katayama I ,Tsukita S Proc Natl Acad Sci U S A. 2016;113(28): E4061-8.
|
|
| |
|
加藤 義治 |
東京女子医科大学整形外科 前教授・講座主任 |
| 整形外科学 運動器学 |
| 研究論文
Katoh Y. Effects of Ethane-1-hydroxy-1,1-diphospho-nate on cell differentiation, and proteoglycan and calcium metabolism in the proximal tibia of young rats. Bone.12: 59-65、1991
|
| 「CKD・透析に併発する運動器疾患」 加藤 義治、稲葉 雅章 編, 加藤 義治, 透析と骨関節障害の病態と治療、108-120, 透析患者の椎体骨折, 195-209, 医薬ジャーナル社, 2018
|
| Itoh Tatsuo，Kato Yoshiharu：Posterior decompression for cervical ossfication of the posterior longitudinal ligament．「Ossification of the Posterior Longitudinal Ligament」（Yonenobu K, Sako T, Ono K eds）Springer，Tokyo：pp218①143-152，1997
|
|
| |
|
小池 隆夫 |
北海道内科リウマチ科病院 最高顧問
北海道大学 名誉教授
|
| リウマチ学・臨床免疫学・内分泌学・糖尿病学 |
| Bohgaki M, Koike T: Chapter 60:Clinical manifestations. George C. Tsokos. SYSTEMIC LUPUS ERYTHEMATOSUS. Basic, Applied and Clinical Aspects. second edition. Academic Press.575-579. 2020.
|
Koike T.
Antiphospholipid syndrome: 30 years and our contribution.
Int J Rheum Dis. 18(2):233-41,2015.
|
Koike T.
My contribution, my dream a look at the future of APS.Lupus. 23(12):1332-1334, 2014.
|
|
| |
|
甲村 英二 |
神戸大学大学院医学研究科 教授
|
| 脳神経外科学 |
| MicroRNA‐10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E. International Journal of Cancer, 2009; 125(6): 1407-1413.
|
| Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. Tanaka K, Sasayama T, Irino Y, Takata K, Nagashima H, Satoh N, Kyotani K, Mizowaki T, Imahori T, Ejima Y, Masui k,Gini B, Yang H, HosodaK, SasakiR, Mischel PS,Kohmura E. Journal of clinical investigation, 2015; 125(4): 1591-1602.
|
| Machine learning to predict in-hospital morbidity and mortality after traumatic brain injury. Matsuo K, Aihara H, Nakai T, Morishita A, Tohma Y, Kohmura E. Journal of Neurotrauma, 2020; 37(1): 202-210.
|
|
| |
|
堺 秀人 |
医療法人仁泉会理事 |
| 腎臓病学 |
AMED腎疾患実用化研究事業の説明、堺秀人、
平成28年度日本腎臓学会総会、2016年6月17日
|
|
| |
|
澤倫太郎 |
日本医師会総合政策研究機構 研究部長・会長特別補佐 |
| 胎児生理学、産科学、医療経済学 |
Sawa R, Asakura H, Power GG.
Changes in plasma adenosine during simulated birth of fetal sheep.
J Appl Physiol 70(4): 1524-1528, 1991
|
Sawa R, Yoneyama Y, Otsubo Y, Suzuki S, Kubonoya K, Power GG,
Araki T.
Fetal plasma hypoxanthine level in growth-retarded fetuses before labor. J Clin Endocrinol Metab 82: 4028-4033, 1997
|
Ishihara O, Seung Chik Jwa, Kuwabara A, Ishikawa T,
Kugu K, Sawa R, Banno K,Saito H
Assisted reproductive technology inJapan: a summary report for 2016
by the Ethics committee of the Japan society of obstetrics and gynecology. Reprod Med Biol.1-10,2018
|
|
|
|
高橋 孝雄 |
慶應義塾大学 教授（医学部小児科） |
| 小児神経学、発達神経生物学 |
| In utero exposure to valproic acid induces neocortical dysgenesis via dysregulation of neural progenitor cell proliferation/differentiation. Fujimura K, Mitsuhashi T, Shibata S, Shimozato S, Takahashi T. J Neurosci 2016;36:10908-10919. |
| Adverse effects of prenatal and early postnatal exposure to antiepileptic drugs: validation from clinical and basic researches. Fujimura K, Mitsuhashi T, Takahashi T. Brain Dev 2017;39: 635-643. |
| Sequence of neuron origin and neocortical laminar fate: relation to cell cycle of origin in the developing murine cerebral wall. Takahashi T, Goto T, Miyama S, Nowakowski RS, Caviness VS Jr. J Neurosci 1999;19:10357-10371 |
|
| |
|
竹中 洋 |
京都府立医科大学 学長 |
| 耳鼻咽喉科学 |
Enhanced human IgE production results from exposure to the aromaticHydrocarbons from diesel exhaust;direct effects on B-cell IgE production, Takenaka H,et al
J Allery CLin Immunol;1998.95:103-115.
|
コア・ローテイション 耳鼻咽喉科・頭頸部外科
編集 竹中洋、高橋姿、久育男
金芳堂、2004年1月5日
|
気道アレルギーの成立とその制御：竹中 洋
第110回日本耳鼻咽喉科学術総会宿題報告
東京、2009.05.14.
|
|
| |
|
坪内博仁 |
鹿児島市立病院 院長 |
| 消化器内科、肝臓病 |
Hepatocyte Growth Factor Facilitates Esophageal Mucosal Repair and Inhibits the Submucosal Fibrosis in a Rat Model of Esophageal Ulcer.
Komaki Y, Kanmura S, Sasaki F, Maeda H, Oda K, Arima S, Tanoue S, Nasu Y, Hashimoto S, Mawatari S, Tsubouchi H, Ido A. Digestion. 2019;99(3):227-238.
|
The recovery of the PT-INR to less than 1.3 predicts survival in patients with severe acute liver injury.
Mawatari S, Moriuchi A, Ohba F, Kawano T, Oda K, Takikawa Y, Takikawa H, Ido A, Tsubouchi H. J Gastroenterol. 2018Jul;53(7):861-872.
|
Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.
Nakao M, Nakayama N, Uchida Y, Tomiya T, Ido A, Sakaida I, Yokosuka O, Takikawa Y, Inoue K, Genda T, Shimizu M, Terai S, Tsubouchi H, Takikawa H, Mochida S. J Gastroenterol. 2018 Jun;53(6):752-769.
|
|
| |
|
永井正規 |
埼玉医科大学名誉教授 |
| 疫学 |
| Prevalence and Incidence of Polymyositis and Dermatomyositis in Japan. Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H.Mod Rheumatol 24:477-480, 2013. |
A case control study of female systemic lupus erythematosus in Japan
MASAKI NAGAI,TOMIO HIROHATA,YOSHIFUJI MATSUMOTO,HIROSHI HASHIMOTO,MASAKAZU KONDO,KOTARO OZASA,MITSURU MORI,TSUTOMU HASHIMOTO,HIDEAK
I NAKAGAWA,TOSHITAKA OMURA,MASAKI MORI,TAKESHI TOJO,HIROSHI YANAGAWA European Journal of Public Health, Volume 3, Issue 3:172-176, 1992
|
| 「新しい疫学」永井正規他共著，日本公衆衛生協会，（1995）． |
|
| |
|
西澤 正豊 |
新潟医療福祉大学 副学長 |
| 脳神経内科学 |
| Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials. Nishizawa M, Onodera O, Hirakawa A, Shimizu Y, Yamada M, Rovatirelin Study Group, J Neurol Neurosurg Psychiatry 91(3): 254-262, 2020.
|
| Assessment of Ataxia Rating Scales and Cerebellar Functional Tests. Critique and recommendations. Perez-Lloret S, van de Warrenburg B, Rossi M, Rodriguez-Blazquez C, Zesiewicz T, Saute JAM, Durr A, Nishizawa M, Martinez-Martin P, Stebbins GT, Schrag A, Skorvanek M, members of the MDS Rating Scales Review Committee: Mov Disord in press, 2020.
|
| Clinicopathological features in anterior visual pathway in neuromyelitis optica. Hokari M, Yokoseki A, Arakawa M, Saji E, Yanagawa K, Yanagimura F, Toyoshima Y, Okamoto K, Ueki S, Hatase T, Ohashi R, Fukuchi T, Akazawa K, Yamada M, Kakita A, Takahashi H, Nishizawa M, Kawachi I: Ann Neurol. 79(4): 605-24, 2016.
|
|
| |
|
貫和敏博 |
東北大学 名誉教授 |
| 呼吸器内科 |
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.
Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group.
J Clin Oncol. 2020 Jan 10;38(2):115-123.
|
| 貫和敏博、肺がん. がん生物学イラストレイテッド、第2版、渋谷正史・湯浅保仁編集、羊土社、2019.
|
Safety and pharmacokinetics of Alpha-1 MP (ProlastinR-C) in Japanese patients with alpha1-antitrypsin (AAT) deficiency.
Seyama K, Nukiwa T, Sato T, Suzuki M, Konno S, Takahashi K, Nishimura M, Steinmann K, Sorrells S, Chen J, Hayashi KI.
Respir Investig. 2019 Jan;57(1):89-96.
|
|
| |
|
平田結喜緒 |
公益財団法人兵庫県予防医学協会 理事、東京医科歯科大学 名誉教授
|
| 内分泌・代謝学、高血圧、糖尿病、心血管病 |
Salusin-β as a powerful endogenous antidispogenic neuropeptide.
Suzuki-Kemuriyamsa N,Nakano-Tateno T,Tani Y,Hirata Y,Schichi M.
Sci.Rep.2016; 6,20988;doi:10.1038/srep20988
|
| PDL-1 expression according to EGFR mutation status in pretreated non-small cell lung cance. Hata A,Katakami N,Nanjo S,Okuda C,Masago K,Fujita S,Yoshida H, Zama H K,Imai Y, Hirata Y. Oncotarget 2017; 8:113807-113816
|
| PDL-１ expression and T７９０M status in EGFR-mutant non-small cell lung cancer.Hata A,Katakami N, Nanjo S,okuda C, Kaji R,Masago K,Fujita S,Yoshida H,Zama H,Imai K, Hirata Y. Lung Cancer 2017; 111:182-189
|
|
| |
|
福島 雅則 |
公益財団法人神戸医療産業都市推進機構 医療イノベーション推進センター センター長
|
| 腫瘍内科学、トランスレーションナルリサーチ、レギュラトリーサイエンス、科学経営学 |
| Yamashita S, Arai H, Bujo H, Masuda D, Ohama T, Ishibashi T, Yanagi K, Doi Y, Nakagawa S, Yamashiro K, Tanabe K, Kita T, Matsuzaki M, Saito Y, Fukushima M, Matsuzawa Y; PROSPECTIVE Study Group.Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)J Atheroscler Thromb. 2020 Apr 24. doi: 10.5551/jat.55327. Online ahead of print.
|
| Nishizawa S, Kojima S, Okada H, Shinke T, Torizuka T, Teramukai S, Fukushima M.Ten-year prospective evaluation of whole-body cancer screening with multiple modalities including [(18)F]fluorodeoxyglucose positron emission tomography in a healthy populationAnn Nucl Med. 2020 May;34(5):358-368. doi: 10.1007/s12149-020-01456-9. Epub 2020 Mar 21.
|
| Nishimura T, Tsai IJ, Yamauchi H, Nakatani E, Fukushima M, Hsu CY.Association of Geomagnetic Disturbances and Suicide Attempts in Taiwan, 1997-2013: A Cross-Sectional StudyInt J Environ Res Public Health. 2020 Feb 12;17(4):1154. doi: 10.3390/ijerph17041154.
|
|
| |
|
宮﨑 久義 |
特定非営利活動法人
日本医療マネジメント学会理事長
|
| 麻酔、病院管理、地域医療、生活習慣病 |
| 癌末期痛に対するモリッカの下垂体破壊術 1.経鼻的下垂体穿刺に必要な基礎的と方法 .宮崎久義,後藤倶子,岡元和文,宇都宮高賢,森岡亨,山室誠,麻酔27:1606-1612.1978 |
| 癌末期痛に対するモリッカの下垂体破壊術 2.その成績と作用機序に対する考察 .宮崎久義,後藤倶子,岡元和文,宇都宮高賢,森岡亨,山室誠,麻酔28(1):77-82.1979 |
| Critical Pathway: Practical applications and its development in Japan.Hisayoshi Miyazaki,Teruhiko Matsushima. JMAJ48(11):568-571.2005 |
|
| |
|
宮下 俊之 |
北里大学医学部 教授
|
| 小児科学、分子遺伝学、分子生物学 |
| Miyashita, T. and Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80, 293-299. |
| Nagao, K., Iwai, Y. and Miyashita, T. RCAN1 is an important mediator of glucocorticoid-induced apoptosis in human leukemic cells. PLOS ONE 2012, 7, e49926 |
| Ikemoto, Y., Takayama, Y., Fujii, K., Masuda, M., Kato, C., Hatsuse, H., Fujitani, K., Nagao, K., Kameyama, K., Ikehara, H., Toyoda, M., Umezawa, A. and Miyashita, T. Somatic mosaicism containing double mutations in PTCH1 revealed by generation of induced pluripotent stem cells from nevoid basal cell carcinoma syndrome. J. Med. Genet. 2017, 54, 579-584 |
|
| |
|
吉栖 正生 |
広島大学大学院医系科学研究科 教授 |
| 循環器病学 |
| Role of osteoprotegerin in arterial calcification: development of new animal model. Orita Y, Yamamoto H, Kohno N, Sugihara M, Honda H, Kawamata S, Mito S, Soe NN, Yoshizumi M. Arterioscler Thromb Vasc Biol. 27:2058-2064, 2007 |
| Unconstrained vital sign monitoring system using an aortic pulse wave sensor. Hagiyama N, Hirano H, Mito A, Soh Z, Fujita E, Ogura Y, Kaneko S, Nakamura R, Saeki N, Kawamoto M, Yoshizumi M, Tsuji T. Sci Rep. 9:17475, 2019 |
| Disruption of osteoprotegerin has complex effects on medial destruction and adventitial fibrosis during mouse abdominal aortic aneurysm formation. Bumdelger B, Otani M, Karasaki K, Sakai C, Ishida M, Kokubo H, Yoshizumi M. PLoS One. 15:e0235553, 2020
|
|
